leisure time -WSS

leisure time

author：Wikipedia 2025-09-30 11:57:34 - browse：8

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： PBM executives asked to testify by House panel

hotspot

focus

WSS

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

As health system earnings go up, health insurance stocks go down

Brain technologies pose threats that are all too real, experts warn

Warren pushes Witty on UnitedHealth's control over physicians

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Black vets could get higher VA benefits if race not used in lung test

The cancer drug shortage isn’t new — and neither are the solutions

US judge blocks portions of new Florida elections law

ChatGPT in medicine: STAT answers readers' burning questions

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Peter Hotez and the public health issue of online harassment

Most antidepressants don't work on kids, teens, study finds

Tori Bowie and the unacceptable rates of Black maternal death

A timeline of the missing Titanic tourist submersible

knowledge

Is it ever OK for doctors to lie to their patients?

PBM executives asked to testify by House panel

10 states plan to sue EPA over standards for residential wood

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

hotspot

Wikipedia

focus

entertainment